Skip to main content
Device/Product Name
Vaxelis
Active ingredients
Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliovirus (inactivated) and haemophilus influenzae type b conjugate vaccine (adsorbed)
AusPAR Date
Published
Submission Number
PM-2021-01695-1-2
Submission Type
New biological medicine
Decision
Approved

Help us improve the Therapeutic Goods Administration site